Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
03 December 2018 | Story Ruan Bruwer
Janko Dreyer
Much will be expected from Kovsie opening batsmen Janko Dreyer at the University Sport South Africa tournament. He has been in great form recently.

The Kovsie Cricket team has enough motivation and are well aware of what’s at stake in the upcoming University Sport South Africa (USSA) championship that will be held in Stellenbosch from 3 to 7 December.

Kovsie Cricket are determined to secure a spot in next year’s Varsity Cricket tournament taking place in Potchefstroom in September, should they emerge as winners of Division B in the competition.

Scoring for the team

They will kick off with a clash against the Walter Sisulu University, followed by fixtures against the Tshwane University of Technology and Wits before the semi-finals on 6 December, with the final following on 7 December 2018.

A number of the Kovsie Cricket squad members have been on rich form with the bat lately. Opening batsman Janko Dreyer scored a century and two half-centuries in his last four innings for the Free State team in November.

Highly rated in SA

Batsmen Raynard van Tonder from the Kovsies Cricket team will feature as one of the most highly-rated young cricketers in the country. The captain of the South African U19 team smashed an unbeaten 250 runs for the Free State in the three-day provincial match last month. Likewise, Wihan Victor also scored a century for the Free State team in October.
More favourable news for the team is that Kovsie Cricket recently defeated the Central University of Technology with 185 runs.

The Kovsie Cricket squad consists of: Dilivio Ridgard, Nathan Roux, Sipho Mavanda, Wihan Victor, Sean Whitehead, Wizzard Ncedane, AJ van Wyk (captain), Nyiko Shikwambana, Jonathan Draai, Marno van Greuning, Beyers Swanepoel, Christo van Staden.

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept